BIOMAT Database Logo BIOMAT Database Logo

Structure-activity relationship studies of pyrrolone antimalarial agents. 2013

Dinakaran Murugesan, and Marcel Kaiser, and Karen L White, and Suzanne Norval, and Jennifer Riley, and Paul G Wyatt, and Susan A Charman, and Kevin D Read, and Clive Yeates, and Ian H Gilbert
Division of Biological Chemistry & Drug Discovery, College of Life Sciences, University of Dundee, Sir James Black Centre, Dow St, Dundee DD1 5EH, UK.

Previously reported pyrrolones, such as TDR32570, exhibited potential as antimalarial agents; however, while these compounds have potent antimalarial activity, they suffer from poor aqueous solubility and metabolic instability. Here, further structure-activity relationship studies are described that aimed to solve the developability issues associated with this series of compounds. In particular, further modifications to the lead pyrrolone, involving replacement of a phenyl ring with a piperidine and removal of a potentially metabolically labile ester by a scaffold hop, gave rise to derivatives with improved in vitro antimalarial activities against Plasmodium falciparum K1, a chloroquine- and pyrimethamine-resistant parasite strain, with some derivatives exhibiting good selectivity for parasite over mammalian (L6) cells. Three representative compounds were selected for evaluation in a rodent model of malaria infection, and the best compound showed improved ability to decrease parasitaemia and a slight increase in survival.

UI MeSH Term Description Entries
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D011739 Pyrimethamine One of the FOLIC ACID ANTAGONISTS that is used as an antimalarial or with a sulfonamide to treat toxoplasmosis. Chloridin,Daraprim,Malocide,Tindurine
D011758 Pyrroles Azoles of one NITROGEN and two double bonds that have aromatic chemical properties. Pyrrole
D002738 Chloroquine The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses. Aralen,Arechine,Arequin,Chingamin,Chlorochin,Chloroquine Sulfate,Chloroquine Sulphate,Khingamin,Nivaquine,Sulfate, Chloroquine,Sulphate, Chloroquine
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000962 Antimalarials Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) Anti-Malarial,Antimalarial,Antimalarial Agent,Antimalarial Drug,Anti-Malarials,Antimalarial Agents,Antimalarial Drugs,Agent, Antimalarial,Agents, Antimalarial,Anti Malarial,Anti Malarials,Drug, Antimalarial,Drugs, Antimalarial
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Dinakaran Murugesan, and Marcel Kaiser, and Karen L White, and Suzanne Norval, and Jennifer Riley, and Paul G Wyatt, and Susan A Charman, and Kevin D Read, and Clive Yeates, and Ian H Gilbert
Synthesis, biological evaluation, Structure - Activity relationship studies of quinoline-imidazole derivatives as potent antimalarial agents.
April 2022, Bioorganic chemistry,
Dinakaran Murugesan, and Marcel Kaiser, and Karen L White, and Suzanne Norval, and Jennifer Riley, and Paul G Wyatt, and Susan A Charman, and Kevin D Read, and Clive Yeates, and Ian H Gilbert
Structure-activity and structure-property relationship studies of spirocyclic chromanes with antimalarial activity.
March 2022, Bioorganic & medicinal chemistry,
Dinakaran Murugesan, and Marcel Kaiser, and Karen L White, and Suzanne Norval, and Jennifer Riley, and Paul G Wyatt, and Susan A Charman, and Kevin D Read, and Clive Yeates, and Ian H Gilbert
Design, synthesis, and structure-activity relationship studies of 4-quinolinyl- and 9-acrydinylhydrazones as potent antimalarial agents.
March 2008, Journal of medicinal chemistry,
Dinakaran Murugesan, and Marcel Kaiser, and Karen L White, and Suzanne Norval, and Jennifer Riley, and Paul G Wyatt, and Susan A Charman, and Kevin D Read, and Clive Yeates, and Ian H Gilbert
Structure-Activity Relationship Studies of Orally Active Antimalarial 2,4-Diamino-thienopyrimidines.
September 2015, Journal of medicinal chemistry,
Dinakaran Murugesan, and Marcel Kaiser, and Karen L White, and Suzanne Norval, and Jennifer Riley, and Paul G Wyatt, and Susan A Charman, and Kevin D Read, and Clive Yeates, and Ian H Gilbert
Structure-Activity Relationship Studies of Antimalarial Plasmodium Proteasome Inhibitors─Part II.
January 2023, Journal of medicinal chemistry,
Dinakaran Murugesan, and Marcel Kaiser, and Karen L White, and Suzanne Norval, and Jennifer Riley, and Paul G Wyatt, and Susan A Charman, and Kevin D Read, and Clive Yeates, and Ian H Gilbert
Structure-activity relationship studies of orally active antimalarial 3,5-substituted 2-aminopyridines.
December 2012, Journal of medicinal chemistry,
Dinakaran Murugesan, and Marcel Kaiser, and Karen L White, and Suzanne Norval, and Jennifer Riley, and Paul G Wyatt, and Susan A Charman, and Kevin D Read, and Clive Yeates, and Ian H Gilbert
Clotrimazole scaffold as an innovative pharmacophore towards potent antimalarial agents: design, synthesis, and biological and structure-activity relationship studies.
March 2008, Journal of medicinal chemistry,
Dinakaran Murugesan, and Marcel Kaiser, and Karen L White, and Suzanne Norval, and Jennifer Riley, and Paul G Wyatt, and Susan A Charman, and Kevin D Read, and Clive Yeates, and Ian H Gilbert
Quantitative structure-activity relationship studies of antimalarial compounds from their calculated mathematical descriptors.
January 2010, SAR and QSAR in environmental research,
Dinakaran Murugesan, and Marcel Kaiser, and Karen L White, and Suzanne Norval, and Jennifer Riley, and Paul G Wyatt, and Susan A Charman, and Kevin D Read, and Clive Yeates, and Ian H Gilbert
Synthesis and structure-activity relationship of disubstituted benzamides as a novel class of antimalarial agents.
July 2012, Bioorganic & medicinal chemistry letters,
Dinakaran Murugesan, and Marcel Kaiser, and Karen L White, and Suzanne Norval, and Jennifer Riley, and Paul G Wyatt, and Susan A Charman, and Kevin D Read, and Clive Yeates, and Ian H Gilbert
Lerisetron Analogues with Antimalarial Properties: Synthesis, Structure-Activity Relationship Studies, and Biological Assessment.
March 2020, ACS omega,
Copied contents to your clipboard!